John C. Gallagher, MD

Department

Medicine

Position

Adjunct Professor

Books

• CRC Press- Taylor and Francis Group
  Gallagher JC. Nutritional Requirements for Calcium and Vitamin D in ‘The physiological Basis of Metabolic Bone Disease’ ed. H Morris, P Anderson, BEC Nordin. BOOK chapter.
  ISBN 9781138198708 2016
• Springer International Publishing
  Gallagher JC. After Vitamin D Supplementation there Is an Increase in Serum 25 Hydroxyvitamin D but no evidence of a Threshold Response in Calcium Absorption. 2016. In ‘Nutritional Influences on Bone Health’ ed. Connie Weaver, Springer International Publishing Switzerland.2016 BOOK chapter., p. 207-215 2016
• National Academies Press
  Dietary Reference Intakes. ‘Calcium and Vitamin D’ Institute of Medicine ed C Ross, C Taylor, A Yaktine. 2011 2011
• Obstetrics and Gynecology
  Gallagher JC. Osteoporosis in ‘Hormone Therapy Report-ACOG’. Obstetrics & Gynecology
  16(5), p. 66-76S 2004
• Cadmus Press
  Gallagher JC.Effect of Estrogen on Bone in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.American Society Bone & Mineral Research 2003
  Fifth Edition, p. 327-330 2003
• Academic Press - New York
  Gallagher JC, Rapuri PB. Osteoporosis: Pathophysiology. in Encyclopedia of Hormones. Academic Press New York 2003 2003
• Rheumatic Disease Clinics of North America
  Gallagher JC. The role of Estrogen in the prevention of Osteoporosis in Rheumatic Disease Clinics of North America .27,(1),84-95,2001
  27 (1), p. 84-95 2001
• Gallagher JC. Osteoporosis. In: Conn's Current Therapy. Eds: R Rakel. WB Saunders. Philadelphia 1999 1999
• Chapman & Hall London
  Gallagher JC. Vitamin D treatment in osteoporosis and osteomalacia. In: Osteoporosis. Eds. J. Stevenson and R. Lindsay . Chapman & Hall. London 1998:, p. 243-256 1998
• Lippincott-Raven
  Gallagher JC. Treatment of osteoporosis with calcium and vitamin D. In: Osteoporosis. Eds. BL Riggs and LJ Melton. Lippincott-Raven, New York. 1996, p. 371-390 1996
• Academic Press
  Gallagher JC. Estrogen: Prevention and Treatment of Osteoporosis. In: Osteoporosis. Eds. Marcus, Feldman and Kelsey. San Diego CA 1996, p. 1191-1208 1996
• The State of the Art Reviews
  Gallagher JC. Antiresorptive therapy in osteoporosis. In: Spine. State of the Art Reviews – Vertebral Osteoporosis. Eds. C. Cooper and J. Reeve. 1994, , p. 199-224 1994
• Conn's Current Therapy
  Gallagher JC. Method of Osteoporosis. In: Conn’s Current Therapy. Ed. Rakel RR, Saunders. 1985. 1985
• CRC Press- Taylor and Francis Group
  Gallagher JC. The Absorption of Calcium in Health and Disease. In: Calcium in Normal and Pathological Biological Systems, Ed. Anghileri L. Cleveland 1982
• University Park Press
  Gallagher JC. Biochemical Effects of Estrogen and Progesterone on Calcium Metabolism, in Recent Advances in Osteoporosis. Ed. DeLuca HF, Parfitt AM, Jee W, Johnston C. University Park Press, Baltimore, p. 215-224 1981
• CRC Press
  Gallagher JC, Nordin BEC. Hormones and calcium metabolism. In: Biochemistry of Women: Clinical Concepts. Currey AS, JV Hewitt, Eds. CRC Press, Ohio, p. 145-163 1974

Articles

• European Journal of Nutrition
  Cashman KD, Kiely ME, Andersen R, Grønborg IM, Tetens I, Tripkovic L, Lanham-New SA, Lamberg-Allardt C, Adebayo FA, Gallagher JC.et.al. Individual participant data (IPD)-level meta-analysis of randomized controlled trials to estimate the vitamin D dietary requirements in dark-skinned individuals resident at high latitude. Eur J Nutr. 2021 Oct 27. 2021
• J Bone Miner Res
  Kaufmann M, Schlingmann KP, Berezin L, Molin A, Sheftel J, Vig M, Gallagher JC, et.al. Differential diagnosis of vitamin D-related hypercalcemia using serum vitamin D metabolite profiling. J Bone Miner Res. 2021 Jul;36(7):1340-1350. 2021
• Clin Endocrinol (Oxf)
  Huayllas MKP, Smith LM, Gallagher JC, Netzel BC, Singh RJ, Kater CE. Steroidogenesis in patients with adrenal incidentalomas: Extended steroid profile measured by liquid chromatography-mass spectrometry after ACTH stimulation and dexamethasone suppression. Clin Endocrinol (Oxf). 2021 Jul;95(1):29-40. 2021
• Osteoporosis International
  Smith LM, Gallagher JC. Reference range for 24-h urine calcium, calcium/creatinine ratio, and correlations with calcium absorption and serum vitamin D metabolites in normal women. Osteoporos Int. 2021 Mar;32(3):539-547. 2021
• Lancet Diabetes Endocrinol.
  John C. Gallagher Md , Gallagher JC. Vitamin D and respiratory infections. Lancet Diabetes Endocrinol. 2021 Feb;9(2):54-56 2021
• Ann Intern Med
  Appel LJ, Michos ED, Mitchell CM, Blackford AL, Sternberg AL, Miller ER 3rd, Juraschek SP, Schrack JA, Szanton SL, Charleston J, Minotti M, Baksh SN, Christenson RH, Coresh J, Drye LT, Guralnik JM, Kalyani RR, Plante TB, Shade DM, Roth DL, Tonascia J; STURDY Collaborative Research Group (Gallagher JC). The Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults : A Response-Adaptive, Randomized Clinical Trial. Ann Intern Med. 2021 Feb;174(2):145-156 2021
• Journal of Internal Medicine
  Smith LM, Gallagher JC. Effect of vitamin D supplementation on total and free25 hydroxyvitamin D and parathyroid hormone. An analysis of two randomizedcontrolled trials. doi:10.1111/joim.12950. Epub 2019 Jul 29. PubMed PMID: 31215092; PubMed Central PMCID: PMC6851404. 
  286(6), p. 651-659 2019
• Menopause
  Gallagher JC. Sodas and colas are associated with an increase in fractures.doi: 10.1097/GME.0000000000001439. PubMedPMID: 31592874; PubMed Central PMCID: PMC6832823. 
  26(11), p. 1229-1231 2019
• Menopause
  Gallagher JC. Advances in osteoporosis from 1970 to 2018.Menopause. 2018 Dec;25. PMID: 30489459 DOI: 10.1097/GME.0000000000001263
  (12), p. 1403-1417 2018
• Lancet Diabetes Endocrinol.
  Gallagher JC. Vitamin D and bone density, fractures, and falls: the end of the story? 2018 Nov; 6. PMID: 30293910 DOI: 10.1016/S2213-8587(18)30269-9
  (11), p. 834-835 2018
• Journal of Internal Medicine
  Smith LM, Gallagher JC, Kaufmann M, Jones G. Effect of increasing doses of vitamin D on bone mineral density and serum N-terminal telopeptide in elderly women: a randomized controlled trial.J Intern Med. 2018 Dec. PMID: 30137647 DOI: 10.1111/joim.12825
  (6), p. 685-693 2018
• Obstetrics and Gynecology
  Surrey E, Taylor HS, Giudice L, Lessey BA, Abrao MS, Archer DF, Diamond MP, Johnson NP, Watts NB, Gallagher JC, Simon JA, Carr BR, Dmowski WP, Leyland N, Singh SS, Rechberger T, Agarwal SK, Duan WR, Schwefel B, Thomas JW, Peloso PM, Ng J, Soliman AM, Chwalisz K. Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies.
  Vol 132, Issue 1, p. 147-160 2018
• Journal of Clinical Endocrinology and Metabolism
  Schwartz JB, Gallagher C, Jorde R, Berg V, Walsh J, Eastell R, Evans AL, Bowles S, Naylor KE, Jones KS, Schoenmakers I, Holick M, Orwoll E, Nielson C, Kaufman M, Jones G, Bouillon R, Lai J, Verotta D, Bikle D. Determination of free 25(OH)D concentrations and their relationships to total 25(OH)D in multiple clinical populations. 2018
• Journal of Steroid Biochemistry and Molecular Biology
  Yalamanchili V, Gallagher JC. Dose ranging effects of Vitamin D3 on the Geriatric Depression Score: A Clinical Trial.
  201 - April, 2018, p. 178:60-64 2018
• Endocrinology and metabolism clinics of North America
  Smith LM, Gallagher. Dietary Vitamin D Intake for the Elderly Population: Update on the Recommended Dietary Allowance for Vitamin D.
  46 (4), p. 871-884 2017
• Endocrinology and metabolism clinics of North America
  Vitamin D: Mechanisms of Action and Clinical Applications. Endocrinol Metab Clin North Am. Editors Gallagher JC, Bikle DD
  46 (4), p. xvii-xviii 2017
• Endocrinology and metabolism clinics of North America
  Smith LM, Gallagher. Dietary Vitamin D Intake for the Elderly Population: Update on the Recommended Dietary Allowance for Vitamin D. Endocrinol Metab Clin North Am. 2017 Dec;46(4):871-884
  December; 46 (4), p. 871-884 2017
• Journal of Steroid Biochemistry and Molecular Biology
  Smith LM, Gallagher JC, Suiter C. Medium doses of daily vitamin D decrease falls and higher doses of daily vitamin D3 increase falls: A randomized clinical trial.
  173, p. 317-322 2017
• Journal of Bone and Mineral Research
  Kaufmann M, Morse N, Molloy BJ, Cooper DP, Schlingmann KP, Molin A, Kottler ML, Gallagher JC, Armas L, Jones Improved Screening Test for Idiopathic Infantile Hypercalcemia Confirms Residual Levels of Serum 24,25-(OH)2 D3 in Affected Patients.
  7, p. 1589-1596 2017
• New England Journal of Medicine
  Taylor HS, Giudice LC, Lessey BA, Abrao MS, Kotarski J, Archer DF, Diamond MP, Surrey E, Johnson NP, Watts NB, Gallagher JC, Simon JA, Carr BR, Dmowski WP, Leyland N, Rowan JP, Duan WR, Ng J, Schwefel B, Thomas JW, Jain RI, Chwalisz K. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.
  1, p. 28-40 2017
• Nature Reviews Endocrinology
  Gallagher JC. Vitamin D and falls - the dosage conundrum. Nat Rev Endocrinol.
  11, p. 680-684 2016
• Menopause
  Gallagher JC, Palacios S, Ryan KA, Yu CR, Pan K, Kendler DL, Mirkin S, Komm BS. Effect of conjugated estrogens/bazedoxifene on postmenopausal bone loss: pooled analysis of two randomized trials.
  10, p. 1083-91 2016

Publications

• Am Soc Bone Mineral Research
  Yalamanchili, Vinod MD, Yalamanchili, Vinod MD; Gallagher J Christopher ,Lynette M Smith. Hypercalciuria on vitamin D and calcium supplementation in older women is associated with higher baseline levels of calcium absorption and serum 1,25dihydroxyvitamin D . Am Soc Bone Mineral Research at Austin, Texas.2022 October 2022
• ASBMR
  Smith LM, Gallagher JC. Vitamin D supplementation improves gait speed in black but not white women. ASBMR (American Society Bone and Mineral) 2021. 2021
• ASBMR
  LeBoff MS, Chou SH, Ratliff KA, Cook NR, Kim E, Cawthon PM, Bauer DC, Black DM, Gallagher JC, Lee IM, Buring JE, Manson JE. Principal Results of Effects of Supplemental Vitamin D on Incident Fractures in Women and Men in the VITamin D and OmegA-3 TriaL (VITAL) ASBMR 2021 2021
• Endocrine Society J Endocrine Society
  Smith LM, Gallagher JC. In a Clinical Trial There Was No Effect of Vitamin D on Physical Performance in Either Black or White Women. Endocrine Society J Endocrine Society. 2021. 2021
• AACE
  Reddy C, Zena M, Gallagher JC, Recker RR, Anderson RJ.Contralateral Atypical Femoral Fracture (AFF) after teriparatide and subsequent anti-resorptive therapy: a management dilemma. AACE /2021. 2021
• AACE
  Reddy Chandrika, Gallagher JC , Taylon Alain. Right adrenal mass with new central necrosis on Computed Tomography after showing long-term stability AACE 2021 2021
• Journal of Steroid Biochemistry and Molecular Biology
  Martel C, Labrie F, Archer DF, Ke Y, Gonthier R, Simard JN, Lavoie L, Vaillancourt M, Montesino M, Balser J, Moyneur É Gallagher JC et al. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal Prasterone for 12 weeks.
  May, 2016, p. 159:142-53 2016
• Journal of Steroid Biochemistry and Molecular Biology
  Martel C, Labrie F, Archer DF, et al. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal Prasterone for 12 weeks.
  May, 2016, p. 159:142-53 2016
• Climacteric
  Palacios S, Kalouche-Khalil L, Rizzoli R, Zapalowski C, Resc H, Adachi JD, Gallagher JC, Feldman RG, Kendler DL, Wang A, Wagman RB, Adami S. Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis. Climacteric. 2015 Jun 1:1-23.
  2015 June, p. 1:1-23 2015
• Menopause
  Gallagher JC. Bone mineral density measurements: how often should bone mineral density be measured in postmenopausal women? Results from the Women's Health Initiative study.
  2015 Jun;22(6), p. 581-3 2015
• Maturitas
  Labrie F, Archer DF, Bouchard C, Girard G, Ayotte N, Gallagher JC, Cusan L, Baron M, Blouin F, Waldbaum AS, Koltun W, Portman DJ, Côté I, Lavoie L, Beauregard A, Labrie C, Martel C, Balser J, Moyneur É; Members of the VVA Prasterone Group. Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study. Maturitas. 2015 May;81(1):46-56
  2015 May;81(1), p. 46-56 2015
• Expert Opinion on Pharmacotherapy
  Tella SH, Gallagher JC. Efficacy of desvenlafaxine succinate for menopausal hot flashes. Expert Opin Pharmacother. 2014 Nov;15(16):2407-18.
  2014 Nov;15(16), p. 2407-18 2014
• European Journal of Clinical Pharmacology
  Tella SH, Gallagher JC. Biological agents in management of osteoporosis. Eur J Clin Pharmacol. 2014 Nov;70(11):1291-301.
  2014 Nov;70(11), p. 1291-301. 2014
• Menopause
  Gallagher JC, Smith LM, Yalamanchili V. Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women. Menopause. 2014 Nov:21(11):1173-80.
  Nov:21(11), p. 1173-80 2014
• Journal of Clinical Endocrinology and Metabolism
  Kaufmann M, Gallagher JC, Peacock M, Schlingmann KP, Konrad M, DeLuca HF, Sigueiro R, Lopez B, Mourino A, Maestro M, St-Arnaud R, Finkelstein JS, Cooper DP, Jones G. Clinical Utility of Simultaneous Quantitation of 25-Hydroxyvitamin D and 24,25-Dihydroxyvitamin D by LC-MS/MS Involving Derivatization With DMEQ-TAD. J Clin Endocrinol Metab. 2014 Jul;99(7):2567-74
  2014 Jul;99(7), p. 2567-74 2014
• J Bone Miner Res
  Gallagher JC, Jindal PS, Smith LM. Vitamin d does not increase calcium absorption in young women: a randomized clinical trial.J Bone Miner Res. 2014 May;29(5):1081-7
  2014 May;29(5), p. 1081-7 2014
• Clinical Obstetrics and Gynecology
  Gallagher JC, Tella SH. Controversies in osteoporosis management: antiresorptive therapy for preventing bone loss: when to use one or two antiresorptive agents?. Clin Obstet Gynecol. 2013 Dec;56(4):749-56.
  2013 Dec;56(4), p. 749-56 2013
• Expert Opinion on Pharmacotherapy
  Tella SH, Gallagher JC. Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause. Expert Opin Pharmacother. 2013 Dec;14(17):2407-20
  2013 Dec;14(17), p. 2407-20 2013
• Journal of Steroid Biochemistry and Molecular Biology
  Tella SH, Gallagher JC. Prevention and treatment of postmenopausal osteoporosis.J Steroid Biochem Mol Biol. 2013 Oct 29. pii: S0960-0760(13)00182-9
  S0960-0760(13), p. 182-9 2013
• Journal of Steroid Biochemistry and Molecular Biology
  Gallagher JC. The effects of calcitriol on falls, fractures and physical performance tests.
  89-90, p. 498-501 2004
• Journal of Steroid Biochemistry and Molecular Biology
  Effect of vitamin D2 supplement use on serum concentrations of 25OHD levels in elderly women.
  89-90, p. 601-604 2004
• Journal of Steroid Biochemistry and Molecular Biology
  Rapuri PB, Gallagher JC, Knezetic JA, Kinyamu HK, Ryschon KL. Association between vitamin D receptor polymorphism and the rate of bone loss in postmenopausal elderly women. Importance of adjusting for dietary and lifestyle factors.
  89-90, p. 500-506 2004
• Menopause
  172. Gallagher JC, Satpathy R, Rafferty K, Haynatzka V. The Effect of Soy Protein Isolate on Bone Metabolism
  11,no3, p. 290-298 2004
• Calcif Tissue Int
  Effect of vitamin D2 and D3 supplement use on serum 25OHD concentration in elderly women in summer and winter
  74, p. 150-156 2004
• Rapuri PB, Gallagher JC, Haynatzka V. Protein Intake- Effect on Bone Mineral Density and the Rate of Bone Loss in elderly Women Am J Clin Nutr
  77, p. 1517-1525 2003
• Abstracts 2003 Rapuri, PB, Gallagher, JC, Haynatzki, G. Response to Treatment with Estrogen is Related to Endogenous Levels of Testosterone and SHBG. J Bone & Min Res 18(S1),2003 149 Rapuri, PB, Gallagher, JC, Haynatzki, G. Serum Total and Bioavailable Testosterone Levels are Associated with Lower BMD in Elderly Women. J Bone & Min Res 18(S1), 2003 150 Rapuri, PB, Gallagher, JC, Haynatzka, V. No Effect of Estrogen Receptor Gene Polymorphisms on Bone Mineral Density, Bone Loss and Treatment Response to Estrogen. J Bone & Min Res 18(S1), 2003 161 Gallagher JC, Satpathy R, Rapuri PB. Effect of Calcitriol on Serum and Urine Calcium. J Bone & Min Res 18(S1), 2003 162 P.B. Rapuri, J.C. Gallagher, G. Haynatzki. .Endogenous Levels of Testosterone and SHBG are Related to BMD. Rate of Bone Loss and Response to Treatment with Estrogen in Elderly Women. Menopause 2003. 2003
• Gallagher JC Rapuri PB, Haynatzka G, Detter JR Effect of Discontinuation of Estrogen, Calcitriol and the Combination of both on Bone Density and Bone Markers J Clin Endocrinol Metab
  87, p. 4923-4923 2002
• Gallagher JC. Tibolone is effective in preventing postmenopausal bone loss. In Women’s Health and Menopause. Ed. Lobo RA, Crosignani PG, Paoletti R, Bruschi F. Kluwer-Boston 2002
• JAMA: Journal of the American Medical Association
  Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH. The Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.
  287(20), p. 2668-76 2002
• J Clin Endocrinol Metab
  Rapuri PB, Kinyamu HK, Gallagher JC, Haynatzka V. Seasonal changes in calciotropic hormones, bone markers, and bone mineral density in elderly women.
  87(5), p. 2024-32 2002
• J Bone Miner Res
  Abstracts 2002 154 Rapuri PB, Gallagher JC, Haynatzki G. Endogenous Levels of Estrogen Determine the Response to Treatment with Hormone Replacement Therapy in Elderly Women. J Bone &Min Res 17(S1),358,2002 155 Gallagher JC, G. Haynatzki G, Fowler s. Effect of Estrogen, Calcitriol or the Combination of Both on Falls and Non Vertebral Fractures in Elderly Women J Bone &Min Res 17(S1),381,2002 156 Lindsay R, Gallagher JC, Kleerekopper M, Northington R, Qi K, Pickar J. Influence of BMI on changes in BMD with multiple doses of conjugated equine estrogens and medroxyprogesterone acetate in early postmenopausal women. J Bone &Min Res17(S1),482, 2002 157 Rapuri PB, J. C. Gallagher JC, Haynatzka V. Vitamin A Intake and Bone Mineral Density Postmenopausal Women. J Bone &Min Res17(S1),285 2002 157 Rapuri PB, Gallagher JC, Haynatzki G. Low Levels of Serum Estradiol contribute to the Rate of Bone Loss in Postmenopausal Elderly Women J Bone &Min Res 17(S1), 163, 2002 2002
• American Journal of Clinical Nutrition
  Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL. Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes.
  74(5), p. 694-700 2001
• Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL. Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr. 2001
  Nov; 74(5), p. 694-700 2001
• Journal of Clinical Endocrinology and Metabolism
  Gallagher JC, Baylink DJ, Freeman R, McClung M. Prevention of Bone Loss with Tibolone in Postmenopausal Women: Results of Two Randomized, Double blind, Placebo controlled, Dose-Finding Studies.
  86 (10), p. 4717-4726 2001
• Menopause
  Heaney, RP, Gallagher JC, Dawson Hughes E, Marcus R, Nieves J. The Role of Calcium in Peri-and postmenopausal women.
  8(2), p. 84-95 2001
• Not Applicable
  Rapuri PB, Gallagher, JC, Knezetic JA, Ryschon, KL. PTH Genotypes and Rate of Bone Loss-Response to Treatment with Estrogen and the Calcitriol in Postmenopausal Women. J Bone Min Res 2001
• Not Applicable
  Rapuri PB, Gallagher JC, Knezetic JA. Influence of Calcium Intake on the Interaction of Vitamin D Receptor Genotypes and the Rate of Bone Loss in Elderly Woemn. J Bone Min Res 2001
• Not Applicable
  Rapuri PB, Gallagher JC, Ryschon KL. Protein intake-Effect om BMD and the rate of bone loss in elderly women. J BOne Min Res 2001
• Not Applicable
  Gallagher, JC, Greenwald M, Wasnich R, Symons J. Dose -related Increases in Bone Mineral Density due to Norethindrone Acetate in Postmenopausal Women Treated with Ethinyl Estradiol. J Bone Min Res 2001
• Not Applicable
  Gallagher, JC, Rapuri PB, Haynatski G, Detter JR. Effect of Discontinuation of Estrogen, Calcitriol, and the Combination of Estrogen and Calcitriol on Bone Mineral Density and Bone Markers. J Bone Min Res 2001
• J Clin Endocrinol Metab
  Gallagher, JC, Fowler S, Sherman SS. Combination treatment with Estrogen and Calcitriol in the prevention of Age-Related Bone Loss.
  18 (8), p. 3618-3628 2001
• Contemporary ObGyn
  Speroff L, Gallagher JC, Pinkerton J, Raisz L, Montgomery Rice V. The impact of low-dose HRT.
  Supplement Issue, p. 4-25 2001
• Menopause
  Gallagher JC. Meeting the bean half way
  8(3), p. 152-3 2001
• J Bone Miner Res
  Abstracts 2001 Rapuri PB, Gallagher JC, Knetezic J, Kinyamu HK .The association between Bone loss and Vitamin D receptor polymorphism and bone loss in elderly women J Bone Min Res 15(S1), 263, 2000. Rapuri PB, Gallagher JC, Knetezic J, Kinyamu HK. Vitamin D receptor genotypes are associated with different responses in BMD to estrogen and calcitriol in Elderly Women .J Bone Min Res 15(S1), 361, 2000. Rapuri PB, Gallagher JC, Knezetic J and Kinyamu HK. High caffeine intake increases the rate of bone loss in elderly women with VDR genotype tt. J Bone Min Res. 15(S1), 535, 2000. Rapuri PB, Gallagher JC, Knezetic JA, Kinyamu HK. Association between bone loss and VDR polymorphism. Importance of Environmental and Life style factors.J Bone Min Res.15 (S1), 364, 2000. 2001
• J. Bone Miner. Res.
  Gallagher JC, Greenwald M, Wasnich R, Symons J. Dose related increases in bone mineral density due to norethindrone acetate in postmenopausal women treated with ethinyl estradiol 2001
• Journal of Bone Mineral Research
  Rapuri PB, Gallagher JC, Ryschon KL. Protein Intake-Effect of BMD and the rate of bone loss in elderly women 2001
• J. Bone Miner. Res.
  Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH. Impact of adding medroxyprogesterone acetate (MPA) to multiple doses of conjugated equine estrogens (CEE) on bone density in postmenopausal women 2001
• J. Bone Miner. Res.
  Rapuri PB, Gallagher JC, Knezetic JA. Influence of Calcium Intake on the interaction of vitamin D receptor genotypes and the rate or bone loss in elderly women 2001
• J. Clin Endo. and Metab.
  Gallagher JC, Fowler S, Sherman SS. Combination treatment with estrogen and calcitriol in the prevention of age related bone loss
  86, p. 3618-3628 2001
• Rapuri PB, Gallagher JC, Balhorn KE, Ryschon KL. Alcohol Intake and Bone metabolism in Elderly Women. Am J Clin Nutr
  72, p. 1206-1213 2000
• 153 Nuti R, Bonucci E, Brancaccio D, Gallagher JC, Gennari C, Mazzuoli G, Passeri M, Sambrook P. The role of calcitriol in the treatment of osteoporosis. Calcif Tissue Int
  66(3), p. 239-40 2000
• Not Applicable
  Rapuri PB, Galagher JC, Knezetic J, Kimyamu HK. High caffeine intake increases the rate of bone loss in elderly women with VDR genotype tt 2000
• Not Applicable
  Rapuri PB, Gallagher JC, Knezetic J, Kimyamu HK. Vitamin D receptor genotypes are associated with different responses in BMD to estrogen and calcitriol in elderly women 2000
• Rapuri PB, Gallagher JC, Balhorn KE, Ryschon KL. Smoking and Bone Metabolism in Elderly women
  27, p. 429-436 2000
• J. Bone Miner. Res.
  Rapuri PB, Gallagher JC, Knezetic J, Kinyamu HK. Association between bone loss and VDR polymorphism. Importance of environmental life style factors
  15(S1), p. 364 2000
• American Journal of Clinical Nutrition
  Rapuri PB, Gallagher JC, Balhorn KE, Ryschon KL. Alcohol Intake and Bone metabolism in elderly women
  72, p. 1206-1213 2000
• Journal of Bone Mineral Research
  Rapuri PB, Gallagher JC, Knezetic JA, Kinyamu HK. The association between bone loss and vitamin D receptor polymorphism and bone loss in elderly women
  15(S1), p. 263 2000
• Bone
  Rapuri PB, Gallagher JC, Balhorn KE, Ryschon KL. Smoking & Bone Metabolism in Elderly Women
  27, p. 429-436 2000
• Santoro N. Altman A, Archer D, Gallagher JC. The promise of HRT. Contemp Ob.Gyn
  June, p. 4-25 2000
• Maturitas
  Gallagher JC. Moderation of the daily dose of HRT: prevention of osteoporosis. Maturitas 33 (1999) S57-S63 Schneider HPG, Gallagher JC Moderation of the daily dose of HRT: benefits for patients Maturitas 33 (1999) S25-29 1999
• Journal of Bone and Mineral Research
  PTHrP(1-34)Analog, Semparatide Acetate (RS-66172), Causes sustained increased in spine in postmenopausal osteoporotic women. Two Randomized placebo-controlled trials. Gallagher JC, Semparatide investigators. ASBMR J Bone & Min Res 1018:S137,1999 1999
• Journal of Bone and Mineral Research
  Tibolone prevents postmenopausal bone loss and is well tolerated: phase III trial results. Gallagher JC, Freeman R, Baylink DK etal. ASBMR J Bone & Min Res 1104:S158,1999 1999
• Journal of Bone and Mineral Research
  The relationship between bone mineral density and bone markers in elderly women: a longitudinal study. Balhorn KE, Thiyyari PP, Bloes K, Gallagher JC. ASBMR J Bone & Min Res F200:S250, 1999 1999
• Journal of Bone and Mineral Research
  Effect of alcohol on bone density in elderly women. Thiyyari P, Balhorn KE, Pease A, Gallagher JC. ASBMR J Bone & Min Res F320:S273, 1999 1999
• Journal of Bone and Mineral Research
  Effect of smoking on intestinal calcium absorption and bone mineral density in elderly women. Thiyyari P, Balhorn KE, Pease A, Gallagher JC. ASBMR J Bone & Min Res SA324:S389, 1999 1999
• Journal of Bone and Mineral Research
  Effect of HRT and/or Calcitriol therapy and its discontinuation on calcium absorption and bone markers in elderly women. Balhorn KE, Thiyyari PP, Gallagher JC. ASBMR J Bone & Min Res SA403:S410, 1999 1999
• Journal of Bone Mineral Research
  Effect of estrogen, calcitriol and a combination of estrogen and calcitriol on bone mineral density and fractures in elderly women. Gallagher JC, Fowler S. ASBMR J Bone & Min Res T364:S209 1999
• Kenny AM, Gallagher JC, Prestwood KM, Gruman CA, Raisz LG. Bone density, bone turnover, and hormone levels in men over age 75 J-Gerontol-A-Biol-Sci-Med-Sci
  November 53(6), p. M419-25 1998
• Gallagher JC, Kinyamu HK, Fowler SE, Dawson-Hughes B, Dalsky GP, Sherman. Calciotropic hormones and bone markers in the elderly. J Bone Min Res
  13(3), p. 475-482 1998
• Kinyamu HK, Gallagher JC, Rafferty KA, Balhorn KE. Dietary calcium and vitamin D intake in elderly women: effect on serum parathyroid hormone and vitamin D metabolites. Am J Clin Nutr
  67, p. 342-8 1998
• Gallagher JC. Vitamin D treatment in osteoporosis and osteomalacia. In: Osteoporosis. Eds. J. Stevenson and R. Lindsay . Chapman & Hall. London, p. 243-256 1998
• Kinyamu HK, Gallagher JC, DeLuca HF, Prahl JM. Age related changes in calcium absorption, intestinal vitamin D receptor and serum 1,25 dihyroxyvitamin D In: Vitamin D. Chemistry, Biology and Clinical Applications of the Steroid Hormone. Eds: Norman, Bouillon, Thomasset. 10th Workshop on Vitamin D.Strasbourg, France, p. 887-888 1997
• Gallagher JC. Calcitriol and 1α hydroxy D3 are effective treatments for osteoporosis. In: Vitamin D. Chemistry, Biology and Clinical Applications of the Steroid Hormone. Eds: Norman,Bouillon,Thomasset.10thWorkshop on Vitamin D. Strasbourg, France, p. 817-822 1997
• Kinyamu HK, Gallagher JC, Prahl JM, DeLuca HF, Petranick KM, Lanspa SJ. Association between intestinal vitamin D receptor, calcium absorption, and serum 1,25 dihydroxyvitamin D in normal young and elderly women. J Bone Miner Res
  12, p. 922-928 1997
• Krall E, Dawson-Hughes B, Hirst K, Gallagher JC, Sherman SS, Dalsky G. Bone mineral density and biochemical markers of bone turnover in healthy elderly men and women. J Gerontology
  52, p. M61-M67 1997
• Kinyamu HK, Gallagher JC, Knezetic JA, DeLuca HF, Prahl JM, Lanspa SJ. Effect of vitamin D receptor genotypes on calcium absorption, duodenal vitamin D receptor concentration, and serum 1,25dihydroxyvitamin D levels in normal women. Calcif Tissue Int
  60, p. 491-495 1997
• Kinyamu HK, Gallagher JC, Balhorn KE, Petranick KM, Rafferty KA. Serum vitamin D metabolites and calcium absorption in normal young and elderly free-living women and in women living in nursing homes Am J Clin Nutr
  65, p. 790-7 1997
• Kinyamu HK, Gallagher JC, Balhorn KE, Petranick KM, Rafferty KA. Serum vitamin D metabolites and calcium absorption in normal young and elderly free-living women and in women living in nursing homes Am J Clin Nutr
  65, p. 790-7 1997
• Gallagher JC. The role of vitamin D in the pathogenesis and treatment of osteoporosis. J. Rheumatology
  23(45), p. 15-18 1996
• Kinyamu HK, Gallagher JC, Petranick K, Ryschon KL. Effect of parathyroid hormone (hPTH (1-34) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women. J Bone Min Res
  11(10), p. 1-11 1996
• Dawson-Hughes B, Fowler SE, Dalsky G, Gallagher C. Sodium excretion influences calcium homeostasis in elderly men and women. Human & Clin Nutr, p. 2107-2112 1996
• Gallagher JC. Estrogen: Prevention and Treatment of Osteoporosis. In: Osteoporosis. Eds. Marcus, Feldman and Kelsey, Academic Press, San Diego CA 1996, p. 1191-1208 1996
• Gallagher JC. Treatment of osteoporosis with calcium and vitamin D. In: Osteoporosis. Eds. BL Riggs and LJ Melton, Lippincott-Raven, New York, p. 371-390 1996
• Gallagher JC, Ravnikar V, Hulka BS, Villablanca AC. HRT: Where do we stand today? Patient Care Supplement
  December, p. 9-16 1995
• Laya M, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern
  RSNA 1995, p. 433-437 1995
• Hopp RJ, Degan JA, Bien RE, Kinberg K, Gallagher JC. Longitudinal assessment of bone mineral density in children with chronic asthma. Ann Allergy, Asthma & Immunol
  75, p. 143-148 1995
• Hopp RJ, Degan JA, Phelan J, Lappe J, Gallagher JC. Cross-sectional study of bone density in asthmatic children. Pediatric Pulm
  20, p. 189-192 1995
• Inoue T, Orimo H, Koshikawa S, ross PD, Gallagher JC, Kanis. Acronym of improved micro densitometry (computed X-ray densitometry). Journal of Bone and Mineral Metabolism
  12(2), p. 51-2 1994
• Bush TL, Dawood MY, Gallagher JC, Hulka BS, Lindsay R, Utian WH. Which patients will benefit from HRT? Patient Care
  Supplement, p. 3-9 1994
• Bush TL, Dawood MY, Gallagher JC, Hulka BS, Lindsay R, Utian WH. Tailoring the regimen to the patient. Patient Care
  Supplement, p. 11-15 1994
• Bush TL, Dawood MY, Gallagher JC, Hulka BS, Lindsay R, Utian WH. Tailoring the regimen to the patient. Patient Care;
  Supplement, p. 11-15 1994
• Bush TL, Dawood MY, Gallagher JC, Hulka BS, Lindsay R, Utian WH. Update: The benefits and risks of HRT. Patient Care Supplement
  December, p. 23-29 1994
• Gallagher JC. Long term treatment of postmenopausal osteoporosis with 1,25-dihydroxyvitamin D3. In: Vitamin D, a Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Applications. Eds. AW Norman, R Bouillon M Thomasset. Walter de Gruyter, Berlin 1994
• Gallagher JC. Vitamin D metabolism and therapy of osteoporosis. Aktuelle Rheumatologie
  S1(19), p. 1-36 1994
• Kable WT, Gallagher JC. Response. Collected Letters. Int Corr Soc Obst Gyn
  35(3), p. 7-8 1994
• Kinberg K, Hopp R, Biven R, Gallagher JC. Bone mineral density in normal and asthmatic children. J Allergy Clin Immunol
  94, p. 490-7 1994
• Gallagher JC. Antiresorptive therapy in osteoporosis. In: Spine. State of the Art Reviews – Vertebral Osteoporosis. Eds. C. Cooper and J. Reeve, p. 199-224 1994
• Bush TL, Dawood MY, Gallagher JC, Hulka BS, Lindsay R, Utian WH. Compliance: Smoothing the way. Patient Care
  Supplement, p. 16-21 1994
• Gallagher JC, Bishop CW, Knutson JC, Mazess RB, DeLuca HF. Effects of increasing doses of 1-alphahydroxyvitamin D2 (1α-OH-D2) on calcium homeostasis in postmenopausal osteopenic women. J. Bone & Min Res
  9(5), p. 607-619 1993
• Gallagher JC. Effect of gonadotropin-releasing hormone agonists on bone metabolism. Sem Rep Endocrin
  11(2), p. 201-207 1993
• Gallagher JC, Fillion A. Calcium and vitamin D. In: Comprehensive Management of Menopause. Eds.Lorrain et al. Springer-Verlag, New York, p. 137-158 1993
• Gallagher JC. Treatment of osteoporosis with vitamin D, vitamin D metabolites or vitamin D analogues. In: Fourth International Symposium on Osteoporosis and Consensus Development Conference. Eds. C.Christiansen and B. Riis, p. 538-540 1993
• Gallagher JC. Pathogenesis of postmenopausal osteoporosis: The role of calcitriol therapy. In: Fourth International Symposium on Osteoporosis and Consensus Development Conference. Eds. C. Christiansen and B. Riis, p. 538-540 1993
• Gallagher JC. Prevention of bone loss in post-menopausal and senile osteoporosis with vitamin D analogues. Osteo Int
  3(1), p. 172-17 1993
• Greep N, Anderson AL, Gallagher JC. Thallassemia minor: a risk factor for osteoporosis? Bone & Mineral
  16, p. 63-72 1992
• Gallagher JC. Vitamin D Metabolism and Therapy in Elderly Subjects. South Med J
  85:S2, p. 43-47 1992
• Gallagher JC. Risks/Benefits of Hormone Replacement Therapy. Cardiovascular Health and Disease in Women. Proceedings of a National Heart, Lung, and Blood Institute Conference. Eds. Wenger NK, L Speroff, Packard B. LeJacq Communications, Connecticut USA 1992
• Eickhoff J, Molczyk L, Gallagher JC. Influence of isotonic, isometric and isokinetic muscle strength on bone mineral density of the spine and femur in young women. Bone & Mineral (in press 1992) 1992
• Gallagher JC. Pathophysiology of Osteoporosis. Seminar Nephrology
  12:2, p. 109-115 1992
• Gallagher JC. Long term treatment in osteoporosis with 1,25 dihydroxyvitamin D therapy. In: Vitamin D: Gene Regulation, Structure-Function Analysis, and Clinical Application. Proceedings of the Eighth Workshop on Vitamin D, Paris, France, 1991.Editors AW Norman, R Bouilon, and M Thomasset 1991
• Gallagher JC, Kable WT. Is ERT contraindicated in vascular disease? International Correspondence Society of Obstetricians & Gynecologists
  151, p. 1980-1984 1991
• Harris ST, Genant HK, Baylink DJ, Gallagher JC, Katz-Karp S, McConnell MA, Green EM, Stoll RW. The effects of estrone sulfate (Ogen) on spinal bone density of post-menopausal women. Arch Intern Med
  151, p. 1980-1984 1991
• Hopp R, Degan J, Gallagher JC, Cassidy JT. Estimation of bone mineral density in children with juvenile rheumatoid arthritis. J Rheumatol
  18, p. 1235-9 1991
• Molczyk L, Thigpen LK, Eickhoff JE, Goldgar D, Gallagher JC. Reliability of testing on knee extensors and flexors in healthy adult women using a cybex II isokinetic dynamometer. J Orthop Sports Phy Ther
  14, p. 37-41 1991
• Gallagher JC, Kable WT. Effect of progestin therapy on cortical and trabecular bone: Comparison with estrogen. Am J Med
  90, p. 171-178 1991
• Gallagher JC, Goldgar D. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study. Ann Intern Med
  113, p. 649-655 1990
• Kimmel DB, Recker RR, Gallagher JC, Vaswani AS, Aloia JF. A comparison of iliac bone histomorphometric data in postmenopausal osteoporotic and normal subjects. Bone & Min
  11:2, p. 217-36 1990
• Genant HK, Baylink DJ, Gallagher JC, Harris ST, Steiger P, Herber M. Effect of estrone sulfate on postmenopausal bone loss. Obst & Gyn
  76, p. 579-58 1990
• Gallagher JC. The pathogenesis of osteoporosis. Bone and Min 19 Gallagher JC. Hormone replacement therapy in the prevention of osteoporosis. Postgrad Med J, p. 15-20 1990
• Weinstein L, Bewtra C, Gallagher JC. Evaluation of a continuous combined low dose regimen of estrogen progestin for treatment of the menopausal patient. Am J Obst & Gyn
  162:6, p. 1534-39 1990
• Kable WT, Gallagher JC, Nachtigall L, Goldgar D. Lipid changes after hormonal replacement therapy for the menopause. J Reprod Med
  35:5, p. 512-18 1990
• Gallagher JC. Management of persistent perimenopausal bleeding. Int. Corr Soc Obstet Gynec
  31:4 1990
• Gallagher JC. Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis. Metab
  39:4:S1, p. 27-29 1990
• Gallagher JC, Riggs BL. Action of 1,25-Dihydroxy vitamin D3 on calcium balance and bone turnover and its effect on vertebral fracture rate. Metab
  39: 4: SI, p. 30-34 1990
• Gallagher JC. The basis for 1,25 dihydroxyvitamin D therapy in the treatment of osteoporosis. In: Osteoporosis: Physiological Basis, Assessment, and Treatment. Editors HF DeLuca and R Mazess, p. 195-199 1990
• Genant HK, Baylink DJ, Gallagher JC. Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol
  161, p. 1842-6 1989
• Gallagher JC. Treatment of osteoporosis with various therapies. Advances in Endocrinology Vol 6 1989. ed. T. Fujita VIth Fuji Hormone Conference
  6 1989
• Hedlund LF, Gallagher JC. The Effect of Age and Menopause on Bone Mineral Density of the Proximal Femur. J Bone & Min Res
  (4) 4, p. 639-642 1989
• Gallagher JC. Changes in Mineral Metabolism with Immobilization/Spaceflight. Workshop on Exercise Considerations for Space Flight. July 1989 (NASA) Houston, Texas 1989
• Gallagher JC. Use of Vitamin D Metabolites in Osteoporosis. Clinical Disorder of Bone and Mineral Metabolism, Eds. Kleerekoper M, Krane SM. Liebert, New York, p. 205-209 1989
• Hedlund LR, Gallagher JC. Increased incidence of hip fracture in osteoporotic women treated with Sodium Fluoride. J Bone & Min Res
  4(2), p. 223-225 1989
• Mazess RB, Gallagher JC, Notelovitz M, Schiff I, Utian W. Monitoring skeletal response to estrogen. Am J Obstet Gyn
  151:4, p. 843-848 1989
• Gallagher JC, Riggs BL, Recker R, Goldgar D. The effect of Calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency. Proc Soc Exp Biol Med
  191 (3), p. 287-292 1989
• Hedlund LR, Gallagher JC. Change in Vertebral Shape in Spinal Osteoporosis. Calcif Tiss Int
  44, p. 168-172 1989
• Gallagher JC. Prevention of Bone Loss by 1,25 dihydroxyvitamin D3 in Osteoporosis. In: Vitamin D.Chemical, Biochemical and Clinical Update. Ed. AW Norman et al. DeGruyter Berlin,, p. 750-752 1988
• Gallagher JC. Estrogen Replacement Update. J Clin Practice in Sex
  14 (5) 1988
• Hedlund LR, Gallagher JC. Vertebral Morphometry in Diagnosis of Spinal Fractures. Bone & Mineral
  5, p. 59-67 1988
• Gallagher JC, Hedlund R, Stoner S, Meeger C. Vertebral Morphometry: Normative Data. Bone & Mineral
  4(2), p. 189-196 1988
• Gallagher JC. Reducing the risks of osteoporosis caused fractures. Human Sexuality, 1988;24 1988
• Kable WT, Gallagher JC. The role of Progesterone in the treatment of PMS. Internat Corr Soc Obst Gyn
  2a(6), p. 5 1988
• Hedlund LR, Gallagher JC. Estrogen Therapy for Postmenopausal Osteoporosis: Current Status. Geriatric Medicine
  7(2), p. 55-63 1988
• Journal of Reproductive Medicine
  Bewtra C, Kable WT, Gallagher JC. The Endometrial Histology & Bleeding Patterns in Menopausal Women Treated with Estrogen and Different Doses of Progestin J Reprod Med
  33(2), p. 205-209 1988
• Gallagher JC. Drug Therapy of Osteoporosis: Calcium, Estrogen and Vitamin D. In: Osteoporosis: Etiology, Diagnosis, and Management. p. 389-402 Eds. Riggs B L, Melton III LJ. Raven Press, New York, p. 389-402 1988
• Gallagher JC, Goldgar D, Moy A. Total Bone Calcium in Normal Women: Effect of Age and Menopause Status. J Bone Min Res
  2, 6, p. 491-496 1987
• Hedlund LR, Gallagher JC. The Effect of Fluoride in Osteoporosis. The Physician and Sportsmedicine,1987
  15(11), p. 111-120 1987
• Kable WT, Gallagher JC. What is the Proper Treatment of Adenomatous Hyperplasia Without Atypia? Int. Corresp. Soc Obst Gynecol
  28, p. 8 1987
• Gallagher JC. Treatment of Osteoporosis with Vitamin D Analogues. In: Osteoporosis: p 70-72 Current Concepts Report of the Seventh Ross Conference on Medical Research. Ross Laboratories, Columbus,Ohio, p. 70-72 1987
• Gallagher JC. Vitamin D Metabolism in Osteoporosis. In Colloquia on Aging. p 17-18, Ed. Cannigia A et al., Instituto Scientifica Roussel Italia, Milano, Italy, No. 2
  2, p. 17-18 1987
• Eisman J, Gallagher JC. Recent advances in the management of osteoporosis. Symposium Sydney Australia. Excerpta Medica, Amsterdam, New York 1986
• Gallagher JC. Estrogens and Alternative Therapies for Osteoporosis. Int Corr Soc Obst Gynecol
  27, p. 3 1986
• Pak CYC, Sakhaee K, Gallagher JC, Parcel C. Attainment of Therapeutic Fluoride Levels in Serum without Major Side Effects Using a Slow-Release Preparation of Sodium Fluoride in Postmenopausal Osteoporosis. J Bone Min Res, 1:563-571
  1, p. 563-571 1986
• Gallagher JC. Prevention of Osteoporosis. Int. Corr Sec Obst, Gyn, 27, 6
  27, p. 6 1986
• Gallagher JC, Recker R. A Comparison between High Dose Calcitriol and Calcium Supplements in Osteoporosis. Vitamin D, Chemical, Biochemical and Clinical Update. Ed. Norman AW, Schaefer K, Grigoleit HG, v. Herrath D, de Gruyter W, Berlin 1985
• Gallagher JC, Goldgar D, Mahoney P, McGill J. Measurement of Spine Density in Normal and Osteoporotic Subjects Using Computerized Tomography. Relationship of Spine Density to Fracture Threshold and Fracture Index. J Comput Assit Tomogr
  9(3), p. 634-635 1985
• Mack LA, Hanson JA, Kilcoyne RF, Ott SM, Gallagher JC, Chestnut CH. Correlation between fracture index and bone densitometry by CT and dual photon absorptiometry in J Comput Assist Tomogr
  9(3), p. 635- 636 1985
• Gallagher JC. Osteoporosis and Fractures. Ayerst Labs 1984
• Gallagher JC. Clinical Simulations in Obstetrics and Gynecology: Osteoporosis Medical Age Publ. Co. Connecticut 1984
• Gallagher JC. The Role of Vitamin D in the Treatment of Postmenopausal Osteoporosis. In Calcium Disorders of Bone. Eds. Christiansen C et. al. Copenhagen 1984
• Gallagher JC. The Use of Calcitriol (1,25 Dihydroxyvitamin D). In: Osteoporosis, in Clinical Disorders of Bone and Mineral Metabolism. Eds. Boy Frame and J Potts. Excerpta Medica S617 1983
• Milhaud G, Christiansen C, Gallagher JC, Reeve J, Seeman E, Chestnut C and Parfitt AM. Pathogenesis and Treatment of Postmenopausal Osteoporosis. Calcif Tissue Int
  35, p. 708-711 1983
• Heaney RP, Gallagher JC, Johnston CC, Neer R, Parfitt AM, Whedon GD. Calcium Nutrition and bone health in the elderly. Am J Clin Nutr
  36, p. 986-1013 1982
• Gallagher JC, Jerpbak CM, Jee WSS, Johnston KA, DeLuca HF, Riggs BL. Administration of 1,25- Dihydroxyvitamin D3 to patients with Postmenopausal Osteoporosis: Short- and long-term Effects on Bone and Calcium Metabolism. Proc Nat Acad. Sci
  79, p. 3325-3329 1982
• Riggs BL, Gallagher JC, DeLuca HF, Zinsmeister AR. Studies on the Mechanism of Impaired Calcium Absorption in Postmenopausal Osteoporosis. In: Vitamin D Clinical, Biochemical and Clinical Endocrinology of Calcium Metabolism. Eds. Norman A et al, W. de Gruyter, Berlin, p. 903-908 1982
• Gallagher JC. The Use of 1,25-Dihydroxyvitamin D3 in Osteoporosis. In: Vitamin D Clinical, Biochemical and Clinical Endocrinology of Calcium Metabolism. Eds. Norman A et al, De Gruyter W, Berlin, p. 903-908 1982
• Parfitt AM, Gallagher JC, Neer R, Heaney RP, Johnston CC, Whedon GD. Vitamin D and bone health in the elderly. Am J Clin Nutr
  36, p. 1014-1031 1982
• Riggs BL, Gallagher JC, DeLuca HF. Disordered Systemic Regulation of Mineral homeostasis as a Cause of Osteoporosis. In: Osteoporosis Recent Advances in Pathogenesis and Treatment, Eds. DeLuca HF, Frost HM, Jee WSS, Johnston CC, Parfitt AM. University Park Press, Baltimore, p. 353-358 1981
• Gallagher JC. Biochemical Effects of Estrogen and Progesterone on Calcium Metabolism, in Recent Advances in Osteoporosis. Ed. DeLuca HF, Parfitt AM, Jee W, Johnston C. University Park Press, Baltimore, p. 215-224 1981
• Arnaud CD, Gallagher JC, Jerpbak CM, Riggs BL. On the Role of Parathyroid Hormone in the Osteoporosis of Aging. In: Osteoporosis: Recent Advances in Pathogenesis and Treatment, Eds. DeLuca HF, Frost HM, Jee WSS, Johnston CC, Parfitt AM. University Park Press, Baltimore, p. 215-224 1981
• Gallagher JC, Riggs BL, DeLuca HF. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocr Metab
  51, p. 1359-1364 1980
• Gallagher JC, Melton LJ, Riggs BL. Examination of Prevalence Rate of possible risk factors in a population with fracture of proximal femur. Clin Orthop & Rel Res
  153, p. 158-165 1980
• Gallagher JC, Melton LJ, Riggs BL, Bergstrath E. Epidemiology of fractures of Proximal Femur in Rochester, Minnesota, USA Clin Orthopaed, & Rel Res
  150, p. 163-171 1980
• Owen RA, Melton LJ, Gallagher JC, Riggs BL. The National cost of Acute Care for Hip Fractures due to Osteoporosis. Clin Orthopaed & Rel Res 150:172-176, 1980
  150, p. 172-176 1980
• Riggs BL, Gallagher JC, DeLuca HF. Serum vitamin D metabolites and intestinal calcium absorption in normal, elderly and osteoporotic subjects. Vitamin D. Basic research and its clinical application. Eds. Norman AW, et. al. de Gruyter W, Berlin, p. 107-113 1979
• Gallagher JC, Riggs BL, Eisman J, Hamston A, Arnaud SB, DeLuca HF. Intestinal calcium absorption and serum vitamin D metabolites in normal and osteoporotic patients. Effect of age and dietary calcium. J Clin Invest
  94, p. 729-736 1979
• Gallagher JC, Riggs BL, DeLuca, HF. Effect of treatment with synthetic 1,25 (OH)2D in postmenopausal osteoporosis. Berlin 1979
• Mayo Clinic
  Riggs BL, Gallagher JC, DeLuca HF, Edis AJ, Lambert PW, Arnaud CD: A syndrome of osteoporosis, increased serum immunoreactive parathyroid hormone and inappropriately low serum 1,25 dihydroxyvitamin D
  53, p. 701-706 1978
• New England Journal of Medicine
  Gallagher JC. and Riggs BL. Nutrition and bone disease
  298, p. 193-195 1978
• Riggs BL, Gallagher JC. Intestinal calcium absorption in postmenopausal osteoporosis: possible role of vitamin D.
  Proceedings of the 6th International Symposium on Parathyroid Hormone (Vancouver, 1977) 1977
• Riggs BL, Gallagher JC. Evidence for bihormonal deficiency stage (estrogen and 1,25-dihydroxyvitamin D) in-patients with postmenopausal osteoporosis. 3rd Workshop on Vitamin D (Asilomar, 1977) in: Vitamin D. Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism. Eds. Norman AW, Schaefer K, Coburn JW, DeLuca HF, Fraser D, Grigoleit HG, Herrath DV 1977
• Horsman A, Gallagher JC, Simpson M, Nordin BEC: Prospective trial of oestrogen and calcium in postmenopausal women. Brit. Med Journal
  2, p. 789-792 1977
• Riggs BL, Gallagher JC. Evidence for bihormonal deficiency stage (estrogen and 1,25-dihydroxyvitamin D) in-patients with postmenopausal osteoporosis. 3rd Workshop on Vitamin D (Asilomar, 1977) in: Vitamin D. Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism. Eds. Norman AW, Schaefer K, Coburn JW, DeLuca HF, Fraser D, Grigoleit HG, Herrath DV 1977
• Nordin BEC, Aaron JW, Gallagher JC, Horsman A, Marshall DH. Are fractures in the elderly preventable? Modern Geriatrics
  4, p. 11-18 1977
• Marshall DH, Gallagher JC, Guha P, Hanes F, Oldfield W, Nordin BEC. Effect of 1, alpha- hydroxycholecalciferol and hormone therapy on the calcium balance of postmenopausal osteoporosis. XII European Symposium on Calcified Tissue Research
  22S, p. 78-84 1977
• Horsman A, Nordin BEC, Gallagher JC, Kirby PA, Milner RM, Simpson M. Observations of sequential changes in bone mass in postmenopausal women: A controlled trial of oestrogen and calcium therapy. XII European Symposium on Calcified Tissues - (York), 1976. Calcified Tissue Research
  22S, p. 78-84 1977
• Klein RC, Arnaud SB, Gallagher JC, DeLuca H, Riggs BL. Intestinal calcium absorption in exogenous hypercortisonism. J Clin Invest
  60, p. 253-259 1977
• Nordin BEC, Marshall DH, Horsman A, Gallagher JC. Oestrogens and calcium metabolism. Sandoz. Ed. D. Hioco, 1976 1976
• Nordin BEC, Wilkinson R, Marshall DH, Gallagher JC, Williams A, Peacock M. Calcium Absorption in the Elderly. XI Symposium on Calcified Tissues - (Copenhagen), 1975. Calcified Tissue Research
  218, p. 442-451 1976
• Nordin BEC, Horsman A, Aaron J, Gallagher JC. Postmenopausal Bone Loss. Current Medical Research and Opinion, Vol. 3, Supple
  3, p. 28-38 1975
• Peacock M, Nordin BEC, Gallagher JC, Varnivides C. Action of 1,alpha hydroxyvitamin D3 in man. 2nd Workshop on vitamin D. Vitamin D and problems Related to Uremic Bone Disease. Eds. Norman AW,Schaefer K, Grigoleit HG, Herrath DV, Ritz E 1975
• Davies T, McNicol GP, Fieldhouse G, Gallagher JC, Nordin BEC. A comparison of the effects of oestriol succinate and ethinyoestradiol on blood coagulation, platelet function and fibrinolysis in postmenopausal women. In: Estrogens in the postmenopause. Frontiers of Hormone Research
  3, p. 185-198 1975
• Nordin BEC, Gallagher JC, Aaron JE, Horsman A. Postmenopausal osteopenia and osteoporosis. In: Estrogens in the Postmenopause. Frontiers of Hormone Research
  3, p. 131-149 1975
• Gallagher JC, Nordin BEC. Effects of oestrogen and progestogen therapy on calcium metabolism in postmenopausal women. In: Estrogens in the Postmenopause. Frontiers of Hormone Research
  3, p. 15-176 1975
• Nordin BEC, Horsman A, Gallagher JC. Effect of various therapies on bone loss in women. In: Calcium Metabolism, Bone and Metabolic Bone Disease. Eds. Kuhlencordt F, Kruse H.P. Publishers, Springer-Verlag, New York, p. 233-242 1975
• Robertson WG, Gallagher JC, Marshall DH, Peacock M, Nordin BEC. Seasonal variations in the urinary excretion of calcium. British Medical Journal 1974
• CRC Press
  Gallagher JC, Nordin BEC. Hormones and calcium metabolism. In: Biochemistry of Women: Clinical Concepts. Currey AS , JV Hewitt, Eds. CRC Press, Ohio, p. 145-163 1974
• Gallagher JC, Nordin BEC. Hormones and the menopause. (Paris) Actualite Genecologiques 4 serie 1974
• Aaron J, Gallagher JC, Nordin BEC. Seasonal variations of histological osteomalacia in femoral neck fracture. Lancet
  II, p. 84 1974
• Gallagher JC, Horsman A, Nordin BEC. Osteoporosis and the menopause. In: Menopausal Syndromes. Greenblatt, Mahesh, McDonagh, Eds. Medcom, New York, p. 38-48 1974
• Peacock M, Gallagher, JC, Nordin BEC. Effect of 1, alpha hydroxy D3 on calcium absorption and bone resorption. Lancet i 1974
• Aaron J, Gallagher JC, Anderson J, Longton EB, Nordin BEC. The incidence of osteomalacia and osteoporosis in fractures of the proximal femur. Lancet i:February 16, 1974 1974
• Nordin BEC, Horsman A, Gallagher JC. The effect of vitamin D on bone loss in spinal osteoporosis. In: Symposium on Bone Mineral Determination (Sweden) 1974
• Cochran M, Cook MG, Gallagher JC, Peacock M. Hypogammglobulinaemia with Whipple’s disease. Postgraduate Medical Journal
  49, p. 355-358 1973
• Gallagher JC, Aaron J, Horsman A, Wilkinson R and Nordin BEC. Corticosteroid Osteoporosis. Clinics in Endocrinology and Metabolism
  2, p. 355-368 1973
• Gallagher JC, Aaron J, Horsman A, Marshall DH, Wilkinson R, Nordin BEC. The crush fracture syndrome in postmenopausal women. Clinics in Endocrinology and Metabolism
  2, p. 293-315 1973
• Gallagher JC, Nordin BEC. Hormones and calcium metabolism Organorama
  10, p. 3-10 1973
• Gallagher JC, Wilkinson R. The effect of ethinyloestradiol on calcium and phosphorus metabolism of postmenopausal women with primary hyperparathyroidism. Clinical Science and Molecular Medicine
  45, p. 785-802 1973
• Gallagher JC and Nordin BEC. Oestrogens and Calcium Metabolism. In: Aging and Estrogens. Frontiers of Hormone Research, 2:Karger, Basel, p. 98-117 1973
• Gallagher JC, Bulusu L, Nordin BEC. Oestrogenic hormones and bone resorption. In: Clinical Aspects of Metabolic Bone Disease. Eds. Frame B, Parfitt AM, Duncan H, International Congress Series No. 270,Excerpta Medica, Amsterdam
  Series 270, p. 266-273 1973
• Journal of Bone Joint Surgery Am.
  Gallagher JC, Aaron J, Nicholson M, Longton E, and Nordin BEC. The rule of osteoporosis and osteomalacia in fractures of the femoral neck. , p. 54B:192 1972
• Nordin BEC, Aaron J, Gallagher JC. and Horsman A. Calcium and bone metabolism in old age. In: Nutrition in Old Age. Ed. LA Carison, Uppsala, Sweden, 1972, pp. 77-85, p. 77-85 1972
• Gallagher JC. and Nordin BEC. Treatment with Oestrogens of Primary Hyperparathyroidism in postmenopausal women. Lancet i: 503-507, 1972
  Lancet i, p. 503-507 1972
• Clinical Endocrinology (Oxford)
  Gallagher JC, Young MM and Nordin BEC. Effect of artificial menopause on plasma and urine calcium and phosphate
  1, p. 57-64 1972
• Bullamore JR., Gallagher JC., Wilkinson R and Nordin BEC. Effect of Age on Calcium Absorption. Lancet 1970
  11, p. 535-537 1970

Editing and Reviews

• N Engl J Med
  New Engl J Med, Lancet (x2), Osteoporosis International (x3), Menopause (x4), BMC Infectious diseases, Calcified Tissue Int. 2021
• Menopause
  Gallagher JC. Letter to the editor. Menopause. 2015 May;22(5):579.
  2015 May;22(5), p. 579 2015

Presentations

• Effects of Vitamin D on Extra skeletal Health Mexico 2022 2022
• Calcium supplementation. Risks-benefits 2022
• Estrogen forever 2021
• Vitamin D update 2021
• Non parathyroid hypercalcemia 2021
• Saudi Arabian Osteoporosis Society. March 18,2021 1.Effects of Vitamin D on Extra skeletal Health 2.Calcium supplementation. Risks-benefits 2021
• Free but not total 25 hydroxyvitamin D is correlated with calcium absorption. Gallagher, JC. ASBMR 2019, Orlando, FL. 2019
• The decrease in serum paraghyroid hormone on vitamin D treatment is similar when comparing increases in serum free on ttal 25 hydroxyvitamin in White and Black Women. Gallagher, JC. Endocrine Society 2019, New Orleans, LA. 2019
• Smith Lynette M., Gallagher JC, Wai Wai Lin,Leon Swinkels. Oral presentation. Effect of treatment with vitamin D3 on Free and Total 25 hydroxyvitamin D in Older and Younger Caucasian and African American women. A randomized clinical trial. Endocrine Society, 2018 2018
• Wei Wei Lin (Endocrine Fellow), Gallagher JC. Smith LS.Poster. Measurement of Serum Free 25-hydroxyvitamin D in Young and Old African American and Caucasian Women. Endocrine Society, 2018. 2018
• Anh Nguyen (Endocrine fellow.) Gallagher JC. Poster.1,25-Dihydroxyvitamin D-mediated Hypercalcemia due to a Fibrotic Granulomatous Lung Disease, Ameliorated by Ketoconazole. Endocrine Society, 2017 2017
• Smith Lynette, Gallagher JC. Oral presentation. Estimation of the Recommended Daily Allowance (RDA) for Vitamin D Intake Using Serum 25 Hydroxyvitamin D Level of 20ng/ml As the End Point, may vary according to the Analytical Measurement Technique used. Endocrine Society, 2017 2017
• Vinod Yalamanchili (Research Fellow), Gallagher JC. Poster. Effect of Vitamin D Supplementation on Depression Scores in Younger Caucasian and Africa-American Women. Endocrine Society, 2017. 2017
• Gallagher JC. "The year in Vitamin D". Clinical update 2017. Oral presentation - Vitamin D workshop 20th, 2017 2017
• Smith Lynette. Gallagher JC. Poster. Estimation of the Recommended Daily Allowance (RDA) for Vitamin D Intake using serum 25 hydroxyvitamin D level of 20ng/ml as the end and comparing two analytical methods of measurement. Poster Vitamin D workshop 20th. 2017 2017
• Singh, Shilpi (Endocrine fellows); George, Andrea; Theertham, Arjun; Gallagher, JC. Poster. Idiopathic Hypoparathyroidism with deafness, renal anomaly. An interesting case of HDR. American Society Clinical Endocrinologists, 2017 2017
• Singh, Shilpi Endocrine fellow; Gallagher, JC. Poster - Insulin drip at >450 units/hour. Drug drug interaction.an interesting case of norepinephrine interfering with insulin. American Society Clinical Endocrinologists, 2017. 2017
• Gallagher JC Yousefian S (Endocrine Fellow), Smith L. Poster - Vitamin D increases fall rates on doses recommended for Geriatric patients. 19th Workshop on Vitamin D, April 2016 in Boston 2016
• Yalamanchili Vinod (Research Fellow), Gallagher JC. Poster - The effect of increasing doses of vitamin D3 treatment on Geriatric Depression scores. 19th Workshop on Vitamin D, 2016 in Boston. 2016
• Yalamanchili Vinod (Research Fellow), Gallagher JC. Poster - Comparison of the Effect of Vitamin D and 1,25 Dihydroxyvitamin D Treatment on Depression Scores in Older Women. Endocrine Society, April 2016 in Boston. 2016
• Singh S (Research Fellow), Gallagher JC, Smith L. Poster - Change in serum 25OHD after Vitamin D is similar in young, old, Caucasian and African American women .19th Workshop on Vitamin D, April 2016 in Boston 2016
• Singh S (Research Fellow), Gallagher JC, Smith L. Oral presentation - The response to vitamin D in serum 25OHD is similar in Caucasian and African American women. Endocrine Society, April 2016. 2016
• Yousefian S (Endocrine Fellow), Gallagher JC, Smith L. Plenary poster award - Effect of vitamin D on Falls. American Society Bone and Mineral Research, 2015. 2016
• Yousefian S (Endocrine Fellow), Gallagher JC. Late breaking poster. Falls are Increased on Recommended Doses of Vitamin D in Elderly. American Society Bone and Mineral Research, 2015 2015
• Gallagher J, Yousefian S, Smith L. Falls are increased on recommended doses of vitamin D in elderly women. Presented at the ASBMR, Seattle, WA, October 11, 2015 2015
• Gallagher J. Meet-the-Professor Session: Calcium and Vitamin D: Current Status. Oral presentation at the ASBMR, Seattle, WA, October 9-12, 2015. 2015
• Saiprasad S (Endocrine Fellow), Gallagher JC. Poster prize, Chronic Functional Hypoparathyroidism due to Magnesium Deficiency, Endocrine Society, 2015 2015
• Yalamanchili, V (Research Fellow), Gallagher JC. ORAL presentation - Incidence of Hypercalciuria and Hypercalcemia during Vitamin D and Calcium Supplementation in Older and Younger Women: A Comparison Between Caucasians and African Americans in Two Randomized Trials. Endocrine Society, 2015 2015
• Yalamanchili, Vinod (Research Fellow), Gallagher JC. Poster. Effect of vitamin D on depression. Endocrine Society, 2015 2015
• Gallagher JC, Glenville Jones. Oral presentation. Metabolic regulation of serum 25 hydroxyvitamin D by 24, 25 hydroxylation is an essential step in preventing vitamin D intoxication. Endocrine Society, 2014. 2014
• Jindal Prachi (Research Fellow), Gallagher JC. Poster. Vitamin D administration and on calcium absorption in young women. Endocrine Society poster, 2014 2014
• Tella Sri (Research Fellow), Gallagher JC, Smith L. Poster - No significant change in Bone mineral density after vitamin D supplementation in young and elderly women. American Society Bone & Mineral Research, 2014. 2014
• Jindal P (Research Fellow), Gallagher JC, Smith L. Poster. Definition and determinants of a normal reference range for 24-hour urine calcium for Caucasian and African American women. American Society Bone and Mineral Research, 2013 2013
• Jindal P (Research Fellow), Gallagher JC, Smith L. Poster. Effect of vitamin d supplementation on calcium absorption in young women. American Society Bone and Mineral Research, 2013 2013
• Yalamanchili, Vinod (Research fellow) Gallagher JC. Poster prize, Dose Response Relationship between Vitamin D Supplementation and Calcium Absorption in Postmenopausal Women. Endocrine Society, 2012 2012
• Yalamanchili, Vinod (Research fellow), Gallagher JC. Oral presentation. Incidence of Hypercalciuria and Hypercalcemia during a Vitamin D Trial in Postmenopausal Women. Endocrine Society, 2012 2012

Awards

• Distinguished Career Research Awarrd
  2013 Recipient - The University Research Award is presented annually at the President's Convocation to recognize faculty for outstanding research and creative work
  Creighton University
• International Vitamin D Career Research Award
• Dietary Requirements for Vitamin D/Calcium
  Institute of Medicine Committee
  Institute of Medicine Committee